Suche Orphan Drug
Weitere Suchoptionen
196 Ergebnis(se)
Wirkstoff(e)
- (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione
- (2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide
- (2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid
- (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidine-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridine-2-yl)-4-fluoropyrrolidine-2-carboxamide
- (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxid-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octan-chlorid
- (R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate
- (Z)-3-(3-(3,5-bis(Trifluormethyl)phenyl-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylhydrazid
- 2,2'-{2-[(1R)-1-({[(2,5- Dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4,4-diyl}Acetessigsäure
- 2-(2-chlorphenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridin-3,6(2H, 5H)-dion
- 2-[4-Methoxy-3-(2-m-benzyl-ethoxy)-benzoylamino]-indan-2-carbonsäure
- 26-Basen-, Einzelstrang-, Phosphodiester-, DNA-Oligonukleotid
- 3-Pentylbenzeneacetic acid sodium salt
- 4-amino-5-oxo-4 (pyridinium-1-ylmethyl) prolin
- 4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid-hydrogen chloride(1/1)
- 5'-ASCSASTSCSASGSTSCSTSGSASUSASASGSCSTSA-3'
- Adalimumab
- Adeno-associated viral vector serotype 8 containing the human alpha-galactosidase A gene
- Adeno-associated viral vector serotype S3 encoding human alpha-galactosidase A cDNA
- Adult human bone-marrow-derived, ex-vivo-expanded, pooled allogeneic mesenchymal stromal cells
- Afatinib
- Agalsidase alfa
- Agalsidase beta
- Aldesleukin
- Allogeneic cultured postnatal thymus-derived tissue
- Antagonist of the complement 5a receptor
- Anti-von Willebrand Aptamer
- Apremilast
- Auf die A1-Domäne des humanen von Willebrand Faktors gerichteter Nanobody
- Autologer, aus Tumorzellen gewonnener gp96 Hitzeschock-Protein-Peptidkomplex
- Autologous adipose tissue-derived mesenchymal stem cells
- Autologous renal cell tumor vaccine
- Aviptadil
- Axitinib
- Bacillus subtilis oxalate decarboxylase
- Bardoxolone methyl
- Bevacizumab
- Bosentan
- Budesonide (oral use)
- Cannabidiol
- Carboxypyrrolidin-hexanoylpyrrolidincarboxylat
- Chimeric IgG monoclonal antibody cG250
- Chimeric fibril-reactive IgG1k monoclonal antibody 11-1F4
- Chimärer monoklonaler anti-Interleukin-6 Antikörper
- Colchicin
- Complement factor H
- Daratumumab
- Defibrotid
- Ecopipam
- Eculizumab
- Ein adeno-assoziierter viraler Vektor vom Serotyp 5, der das humane Alanin-Glyoxylat-Aminotransferase-Gen enthält
- Eprodisate
- Everolimus
- Fraktion autologer, mononukleärer Zellen aus dem Knochenmark
- Fresolimumab
- Gefitinib
- Genetically modified allogeneic (human) tumour cells for the expression of IL-7, GM-CSF, CD80 and CD154, ...with...(dSLIM)
- Gevokizumab
- Gusperimus trihydrochloride
- HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET-MMPMMPMUC-RGS
- Human interleukin-2 (glycosylated tetrasaccharide, glycosylated trisaccharide and nonglycosylated) (inhalation use)
- Humaner rekombinanter Minibody gegen den Komplementfaktor C5
- Humanized anti-KSA monoclonal antibody-human interleukin-2 fusion protein
- Humansierter IgG1-kappa-Antikörper gegen Serum-Amyloid A und AL-Amyloid
- Immunoglobulin G-degrading enzyme of Streptococcus pyogenes
- Immunoglobulin vom menschen
- Interferon gamma-1B
- Iodine (123I) Serum Amyloid P
- Iodine (131I) chimeric IgG monoclonal antibody cG250
- L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser
- L-cystine bis(N-methylpiperazide)
- Lentiviraler Vektor der das Fanconi-Anämie A (FANCA) Gen beinhaltet
- Levamisolhydrochlorid
- Mepolizumab
- Migalastat hydrochloride
- Mirdametinib
- Modified mRNA encoding human methylmalonyl-coenzyme A mutase encapsulated into lipid nanoparticles
- N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide
- N-Butyldeoxygalactonojirimycin
- N-Hydroxy-4-(3-methyl-2-(S)-phenyl-Butyrylamino) benzamid
- N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)-Harnstoff-Hydrochlorid-Monohydrat
- Naptumomab estafenatox
- Natives bovines Hautkollagen Typ I
- Natriumthiosulfat
- Nintedanib
- Nitisinone
- Nitroglycerin
- Oxalobacter formigenes Stamm HC-1
- Paquinimod
- Pazopanibhydrochlorid
- Pegunigalsidase alfa
- Peptide 144 TGF-beta1-inhibitor (TSLDASIIWAMMQN)
- Poly(oxy-1,2-ethanediyl),.alpha.-hydro-.omega.-hydroxy-,15,15'-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide)
- Pomalidomid
- Propagermanium
- Recombinant human ADAMTS-13
- Recombinant human interleukin-21
- Recombinant human lecithin cholesterol acyltransferase
- Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2
- Recombinant human monoclonal antibody to human IL-1beta of the IgG1/K class
- Recombinant humanised anti-human interleukin-1 beta monoclonal antibody
- Recombinant modified vaccinia Ankara expressing human 5T4
- Rekombinante Variante von Interferon-alpha-2b , wobei der Restbestand von menschlichem Gluatamat an Position 41 von Glutamin ersetzt wird
- Rekombinanter monoklonaler Antikörper gegen die humane Serum Amyloid P Komponente
- Resunab
- Rilonacept
- Riociguat
- Rituximab
- S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)
- Selumetinib
- Setmelanotide
- Single stranded, chemically modified oligonucleotide that binds to and inhibits the function of micro RNA-21
- Sirolimus (Rapamycin)
- Sorafenibtosylat
- Stickstoffmonoxid
- Stiripentol
- Sunitinib
- Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene
- Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues
- Talactoferrinum alfa
- Temsirolimus
- Tergurid
- Tiopronin
- Tocilizumab
- Treprostinil diethanolamine (oral use)
- Tripotassium citrate monohydrate and potassium hydrogen carbonate
- adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA
- autologous adipose tissue-derived stromal vascular fraction cells
- caprine hyperimmune serum against HIV lysate
- equine immunoglobulin F(ab')2 fragments targeting Shiga toxin
- florbetaben (18F)
- human engineered monoclonal antibody specific for transforming growth factor ß1 (TGF- ß1)
- romilkimab
- siponimob
- small interference ribonucleic acid (siRNA) molecule conjugated to N-acteylgalactosamine (GalNAc) oxalate modulator
- ziritaxestat
Handelsname(n)
- AFINITOR
- AVASTIN
- Aybintio
- BLITZIMA
- Bavencio
- CABLIVI
- CABOMETYX
- COLCHICINE HOUDE
- COLCHIMAX
- COLCRYS
- DISULONE
- ENDOXAN
- Equidacent
- FABRAZYME
- FOTIVDA
- GALAFOLD
- GENOTONORM
- ILARIS
- INLYTA
- KEYTRUDA
- KINERET
- KISPLYX
- LENVIMA
- MABTHERA
- MAXOMAT
- NEXAVAR
- NITISINONE MDK
- NITYR
- NORDITROPINE
- NUCALA
- OFEV
- OMNITROPE
- OPDIVO
- ORFADIN
- OTEZLA
- PROCYSBI
- PROLEUKIN
- REPLAGAL
- RILONACEPT REGENERON
- RITEMVIA
- RITUXAN
- RITUZENA
- RIXATHON
- RIXIMYO
- ROACTEMRA
- Ruxience
- SAIZEN
- SOLIRIS
- STAYVEER
- SUTENT
- THIOLA
- TORISEL
- TRACLEER
- TRUXIMA
- UMATROPE
- VALTROPIN
- VEDROP
- VOTRIENT
- VOTUBIA
- YERVOY
- ZOMACTON